Acurx Pharmaceuticals Inc

NASDAQ:ACXP   9:40:06 AM EDT
2.76
+0.11 (+4.15%)
Earnings Announcements

Acurx Pharmaceuticals, Inc. Reports First Quarter 2022 Results And Provides Business Update

Published: 05/11/2022 11:13 GMT
Acurx Pharmaceuticals Inc (ACXP) - Acurx Pharmaceuticals, Inc. Reports First Quarter 2022 Results and Provides Business Update.
Q1 Loss per Share $0.26.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.33

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.35

More details on our Analysts Page.